The aim of this review is to provide an overview of the current literature regarding the role of SLC7A11 in ovarian cancer in order to provide new insights into SLC7A11 modulation and to evaluate the potential role of SLC7A11 as a therapeutic target. This evidence concerns the gene SLC7A11 and ovarian carcinoma.